NEW YORK, Aug. 4 (GenomeWeb News) - Shares in Fisher Scientific were down 5.57 percent, or $3.67, at $62.25 in mid-afternoon trading one day after the company reported strong second-quarter revenue growth, and that it would acquire cellular imaging company Cellomics.


To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.